| Literature DB >> 26449631 |
Jean-Louis Dargent1, Stéphanie Henne2, Delphine Pranger3, Piera Balzarini4, Daniel Sartenaer1, Geneviève Bulliard5, Katrina Rack1, Fabio Facchetti4.
Abstract
Plasmacytoid dendritic cells (PDC) belong to a subtype of dendritic cells that are normally absent in healthy skin. In some inflammatory diseases of the skin, especially lupus erythematosus (LE), these cells are occasionally recruited in great amounts, which can be used as a helpful clue for diagnosis. Rarely, PDC may also accumulate in the skin of patients with myeloid leukemia, a yet poorly known condition currently called 'tumor-forming PDC associated with myeloid neoplasms'. In this study, we describe a patient with unsuspected chronic myelomonocytic leukemia who developed cutaneous lesions characterized by a dermal infiltrate rich in PDC. Similarly to LE, such neoplastic PDC were accompanied by interface dermatitis-like changes, but displayed an aberrant phenotype and shared the same chromosomal abnormality with the leukemic cells identified in the bone marrow, thus revealing the neoplastic nature of the process. This observation illustrates that tumor-forming PDC associated with myeloid neoplasms may microscopically mimic LE in some patients. Accordingly, a hematologic workup is recommended in any skin lesion featuring excessive numbers of PDC, even if morphological alterations suggestive of interface dermatitis are found.Entities:
Keywords: chronic myelomonocytic leukemia; lupus erythematosus; plasmacytoid dendritic cells
Mesh:
Year: 2015 PMID: 26449631 DOI: 10.1111/cup.12639
Source DB: PubMed Journal: J Cutan Pathol ISSN: 0303-6987 Impact factor: 1.587